NRXS Trademark
Serial Number: 50129244
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Brian J. McGinnis Barnes & Thornburg LLP
11 South Meridian Street
Indianapolis, IN 46204
United States
Trademark Details
Filing Date
September 25, 2026
Registration Date
Not Registered
Goods & Services
medical devices, namely, devices for measuring pelvic floor dysfunction and rectal hypersensitivity for use in the diagnosis and treatment of chronic constipation; medical diagnostic apparatus for testing pelvic floor dysfunction and rectal hypersensitivity in the field of chronic constipation; medical devices and apparatus for medical screening testing of individuals with chronic constipation; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the field of chronic constipation; disposable medical devices for diagnosing and treating constipation; Medical apparatus, namely, electrical nerve stimulators; Medical device, namely, a non-implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral nerves; Medical apparatus consisting of percutaneously implantable arrays for transmitting current into auricular and peri-auricular tissue; Medical device for peripheral nerve and nerve field stimulation; Medical device consisting of a non-implantable modulating frequency generator and percutaneously implantable needle arrays for transmitting current into auricular and peri-auricular tissue for use in pain management and FGID (functional gastrointestinal disorders), namely, patient stimulator for auricular and peri-auricular peripheral nerve field neuromodulation therapy; Medical apparatus, for peripheral nerve field stimulation in cranial and peripheral nerves and occipital nerve branches, for pain control, FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea, functional nausea, abdominal migraine, Crohn's Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes in FGID co-morbidities, sleep disturbances, psychological disorders, including mood and anxiety, satiety and changes in autonomic nervous system and other types of sympathetically mediated pain